Fredika M. Robertson

Affiliations: 
Ohio State University, Columbus, Columbus, OH 
Area:
Oncology, Pathology, Biochemistry
Google:
"Fredika Robertson"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Morlacchi P, Robertson FM, Klostergaard J, et al. (2014) Targeting SH2 domains in breast cancer. Future Medicinal Chemistry. 6: 1909-26
Bertucci F, Ueno NT, Finetti P, et al. (2014) Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 358-65
Fernandez SV, Robertson FM, Addya S, et al. (2014) Abstract 4988: Clues for targeted therapies in inflammatory breast cancer (IBC) Cancer Research. 74: 4988-4988
Robertson FM, Chu K, Boley KM, et al. (2013) The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis. Journal of Experimental Therapeutics & Oncology. 10: 219-33
Robertson FM, Petricoin Iii EF, Van Laere SJ, et al. (2013) Presence of anaplastic lymphoma kinase in inflammatory breast cancer. Springerplus. 2: 497
Fernandez SV, Robertson FM, Pei J, et al. (2013) Inflammatory breast cancer (IBC): clues for targeted therapies. Breast Cancer Research and Treatment. 140: 23-33
Zhang EY, Cristofanilli M, Robertson F, et al. (2013) Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer. Journal of Proteome Research. 12: 2805-17
Chu K, Boley KM, Moraes R, et al. (2013) The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism. Oncotarget. 4: 446-62
Van Laere SJ, Ueno NT, Finetti P, et al. (2013) Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4685-96
Chu K, Green T, Boley K, et al. (2013) Abstract P6-12-14: Histone deacetylase inhibitor suberoylanilide hydroxamic acid targets breast cancer stem cells and inhibits metastasis Cancer Research. 73
See more...